Novo Nordisk Lilly Shares Slump on Price-Cut Loom Plans
News of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
Plan zero based budgets for families to create a shared financial vision, allocate funds, and pursue common goals together.
19,937 articlesNews of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
The financial sector kicks off 2026 with its sharpest early-year drop in a decade. Analysts say high-ROE, low-P/E scr...
When Amazon signaled massive AI and data center investments, its stock tumbled. This guide explains why that drop cou...
Six AI-driven forecasts clash with Standard Chartered’s trimmed XRP target, spotlighting how ETF dynamics and policy ...
Boyd Group stock since its IPO has posted a meaningful climb. This piece breaks down the factors behind the move, wha...
A prominent market strategist argues the brutal tech and crypto rout may be nearing a bottom as risk assets stabilize...
When rhythm pharma (rytm) releases earnings, investors get a window into revenue growth, cash health, and pipeline pr...
Google’s Gemini AI lays out aggressive price targets for XRP, DOGE, and SHIB through 2026, sparking debate about odds...
A sharp rally in Chime Financial shares followed stronger-than-expected Q4 guidance. This piece breaks down the drive...
Across software-as-a-service stocks, Wix has been a standout case of a dramatic pullback. This piece breaks down why ...
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
A Manhattan federal judge rejected Binance’s bid to compel private arbitration, allowing a class-action alleging unre...